Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Embecta Corp (EMBC)

Embecta Corp (EMBC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,200,426
  • Shares Outstanding, K 58,132
  • Annual Sales, $ 1,123 M
  • Annual Income, $ 78,300 K
  • EBIT $ 167 M
  • EBITDA $ 216 M
  • 60-Month Beta 1.25
  • Price/Sales 1.06
  • Price/Cash Flow 6.14
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 52.89% ( -7.56%)
  • Historical Volatility 85.18%
  • IV Percentile 9%
  • IV Rank 30.35%
  • IV High 129.12% on 03/15/24
  • IV Low 19.67% on 06/03/24
  • Put/Call Vol Ratio 0.08
  • Today's Volume 14
  • Volume Avg (30-Day) 32
  • Put/Call OI Ratio 0.56
  • Today's Open Interest 2,016
  • Open Int (30-Day) 2,556

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.45
  • Number of Estimates 2
  • High Estimate 0.46
  • Low Estimate 0.43
  • Prior Year 0.60
  • Growth Rate Est. (year over year) -25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.92 +9.14%
on 12/06/24
21.48 -3.86%
on 12/02/24
-0.18 (-0.86%)
since 11/29/24
3-Month
12.42 +66.26%
on 10/10/24
21.48 -3.86%
on 12/02/24
+6.55 (+46.45%)
since 09/30/24
52-Week
9.93 +108.06%
on 04/15/24
21.48 -3.86%
on 12/02/24
+1.72 (+9.09%)
since 12/29/23

Most Recent Stories

More News
Here's Why You Should Add Ensign Group Stock to Your Portfolio Now

The Ensign Group, Inc. ENSG is benefiting from strategic acquisitions, an expanding footprint, rising service revenues and a strong financial position. An optimistic 2024 business outlook also reinforces...

VCYT : 39.71 (+0.28%)
EMBC : 20.72 (+0.34%)
CDNA : 21.75 (+1.59%)
ENSG : 133.33 (+0.35%)
Zacks.com featured highlights include The Gap, Embecta, Blue Bird and ZIM Integrated Shipping Services

For Immediate ReleaseChicago, IL – December 24, 2024 – Stocks in this week’s article are The Gap Inc. GAP, Embecta Corp. EMBC, Blue Bird BLBD and ZIM Integrated Shipping Services ZIM.4 Best-Bargain...

BLBD : 39.42 (+2.05%)
GAP : 24.11 (+2.03%)
EMBC : 20.72 (+0.34%)
ZIM : 22.26 (+3.68%)
4 Best-Bargain PEG Stocks That Value Investors Love

With the market getting increasingly fickle on external shocks, investors are more focused on finding an investment strategy that emphasizes judging a stock's inherent potential. Needless to mention, value...

BLBD : 39.42 (+2.05%)
GAP : 24.11 (+2.03%)
EMBC : 20.72 (+0.34%)
ZIM : 22.26 (+3.68%)
embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference

EMBC : 20.72 (+0.34%)
Best Value Stocks to Buy for December 2nd

Here are three stocks with buy rank and strong value characteristics for investors to consider today, December 2:Embecta Corp. EMBC: This medical device company carries a Zacks Rank #1, and has witnessed...

BLBD : 39.42 (+2.05%)
ENVA : 96.61 (+0.76%)
EMBC : 20.72 (+0.34%)
Best Income Stocks to Buy for December 2nd

Here are two stocks with buy rank and strong income characteristics for investors to consider today, December 2:Community Trust Bancorp, Inc. CTBI: This bank holding company for Community Trust Bank has...

CTBI : 53.59 (+1.06%)
EMBC : 20.72 (+0.34%)
Stocks Finish Lower on Mixed Economic News and Tech Stock Weakness

The S&P 500 Index ($SPX ) (SPY ) Wednesday closed down -0.38%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.31%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.85%. Stocks on...

AMAT : 164.81 (+1.34%)
AVGO : 234.67 (+1.22%)
PARA : 10.53 (+0.67%)
FL : 22.05 (+1.33%)
HPQ : 32.61 (-0.06%)
EMBC : 20.72 (+0.34%)
TXN : 189.58 (+1.10%)
$IUXX : 21,012.17 (-0.87%)
URBN : 55.49 (+1.11%)
ZNH25 : 108-315 (+0.22%)
GFS : 43.37 (+1.07%)
LRCX : 73.00 (+1.07%)
Stocks Slip as Mixed Economic News Warrants a Cautious Fed

The S&P 500 Index ($SPX ) (SPY ) today is down -0.33%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.03%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.12%. Stocks today are mixed, with...

CRWD : 345.07 (+0.85%)
ADSK : 296.42 (+0.29%)
PARA : 10.53 (+0.67%)
$SPX : 5,881.63 (-0.43%)
SYM : 24.13 (+1.77%)
FL : 22.05 (+1.33%)
HPQ : 32.61 (-0.06%)
EMBC : 20.72 (+0.34%)
$IUXX : 21,012.17 (-0.87%)
WDAY : 257.66 (-0.14%)
URBN : 55.49 (+1.11%)
UNH : 510.01 (+0.82%)
Embecta Corp. Declares Quarterly Cash Dividend of $0.15 Per Share

Embecta Corp. declared a quarterly cash dividend of $0.15, payable December 18, 2024, to eligible shareholders.Quiver AI SummaryEmbecta Corp. has announced a quarterly cash dividend of $0.15 per share...

EMBC : 20.72 (+0.34%)
Embecta Corp. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2025 Financial Guidance; Discontinues Insulin Patch Pump Program; and Announces Restructuring to Streamline Operations and Reduce Costs

EMBC : 20.72 (+0.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Embecta Corp. is a pure-play diabetes care company. Embecta is based in FRANKLIN LAKES, N.J.

See More

Key Turning Points

3rd Resistance Point 21.40
2nd Resistance Point 21.19
1st Resistance Point 20.92
Last Price 20.72
1st Support Level 20.44
2nd Support Level 20.23
3rd Support Level 19.96

See More

52-Week High 21.48
Last Price 20.72
Fibonacci 61.8% 17.07
Fibonacci 50% 15.70
Fibonacci 38.2% 14.34
52-Week Low 9.93

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar